Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports
<p>Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in t...
Պահպանված է:
| Հիմնական հեղինակներ: | , , |
|---|---|
| Ձևաչափ: | Գիրք |
| Հրապարակվել է: |
Archives of Hepatitis Research - Peertechz Publications,
2017-05-29.
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | Connect to this object online. |
| Ցուցիչներ: |
Ավելացրեք ցուցիչ
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
|
| Ամփոփում: | <p>Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in the drug instruction of ETV. Here we report two CHB patients with ETV-associated constipation in whom symptom fully disappeared following ETV withdrawal.</p> |
|---|---|
| DOI: | 10.17352/ahr.000013 |